Scientific Congress & Conference Publication Summary

Progressive Multiple Sclerosis

Congress / Conference Year Delivered by Title Presentation
Americas and European Committees for Treatment and Research in Multiple Sclerosis (ACTRIMS-ECTRIMS) Annual Congress: MSVirtual2020 2020 Prof Patrick Vermersch Masitinib in Primary Progressive (PPMS) and Non-Active Secondary Progressive (nSPMS) Multiple Sclerosis: Results from Phase 3 Study AB07002 Abstract
Masitinib in Primary Progressive (PPMS) and Non-Active Secondary Progressive (nSPMS) Multiple Sclerosis: Results from Phase 3 Study AB07002 Platform Presentation

Severe Asthma

Congress / Conference

Year

Delivered by
Title

Presentation

American Thoracic Society

ATS 2020 VIRTUAL

2020

Prof Pascal Chanez Masitinib Significantly Decreases the Rate of Asthma Exacerbations in Patients with Severe Asthma Uncontrolled by Oral Corticosteroids: A phase 3 Multicenter Study

Abstract

Poster

Platform Presentation

European Respiratory Society

ERS2020 ALERT

2020

Prof Pascal Chanez Masitinib in Severe Asthma: Results from a Randomized, Phase 3 Trial

Platform Presentation

Poster

Abstract

European Academy of Allergy & Clinical Immunology (EAACI) 2020 Congress

2020

Prof Lavinia Davidescu Efficacy and Safety of Masitinib in Severe Asthma: Results From Study AB07015

Platform Presentation

Efficacy and Safety of Masitinib in Severe Asthma: Eosinophilic Subgroup Analysis from Study AB07015

Abstract

Amyotrophic Lateral Sclerosis

Congress / Conference Year Delivered by Title Presentation
ENCALS Annual Meeting 2018 Dr Jesus S Mora Initiation of Masitinib at a Less Severe Stage of Disease Produces Greater Treatment-Effect: Subgroup Analyses from Masitinib Study AB10015 Abstract / Poster
2018 Prof Olivier Hermine Sensitivity Analyses from the First Phase 3 Clinical Study of Masitinib (AB10015) in ALS Demonstrate Robustness of the Positive Primary Analysis Abstract / Poster
2018 Prof Luis Barbeito Masitinib therapeutically targets sciatic nerve pathology associated with paralysis progression in an inherited ALS model Abstract

Alzheimer’s Disease

Congress / Conference

Year

Delivered by Title

Presentation

14th International Athens/Springfield Symposium on Advances in Alzheimer Therapy

2016

Prof Olivier Hermine Masitinib for the Treatment of Alzheimer’s Disease: Clinical and Preclinical Data

Platform Presentation / Abstract

Masitinib for the Treatment of Alzheimer’s Disease: a Randomized Phase 3 Trial

Poster

AB8939

Congress / Conference Year Delivered by Title Presentation
European Hematology Association (EHA) Annual Congress 2020 Prof Olivier Hermine AB8939, a Novel Microtubule-Destabilizing Agent for the Treatment of Acute Myeloid Leukemia Poster
American Society of Hematology (ASH) Annual Meeting 2019 Prof Olivier Hermine Anticancer Activity of a Highly Potent Small Molecule Tubulin Polymerization Inhibitor, AB8939 Abstract / Poster
AB8939, a Microtubule-Destabilizing Agent with Potential to Overcome Multidrug Resistance, is Active Across the Range (M0–M7) of Acute Myeloid Leukemia Subtypes Abstract
In Vivo Assessment of the Next Generation Microtubule-Destabilizing Agent AB8939 in Patient-derived Xenograft Models of Acute Myeloid Leukemia Abstract